These results suggest that both erastin and sulfasalazine can induce the ferroptosis of AML cells by inhibiting system Xc− activity, thereby reducing intracellular GSH levels and inhibiting GPX4 activity. The gene discussed is GPX4; the disease is acute myeloid leukemia.